Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of 2.16 billion. The enterprise value is 2.25 billion.
| Market Cap | 2.16B |
| Enterprise Value | 2.25B |
Important Dates
The next estimated earnings date is Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | May 2, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 75.04M |
Valuation Ratios
The trailing PE ratio is 43.50 and the forward PE ratio is 34.61.
| PE Ratio | 43.50 |
| Forward PE | 34.61 |
| PS Ratio | 6.00 |
| PB Ratio | 1.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 31.62 |
| P/OCF Ratio | 27.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.08, with an EV/FCF ratio of 32.99.
| EV / Earnings | 45.38 |
| EV / Sales | 6.01 |
| EV / EBITDA | 18.08 |
| EV / EBIT | 28.05 |
| EV / FCF | 32.99 |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.77 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 2.85 |
| Interest Coverage | 8.41 |
Financial Efficiency
Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 3.18%.
| Return on Equity (ROE) | 3.78% |
| Return on Assets (ROA) | 2.89% |
| Return on Invested Capital (ROIC) | 3.18% |
| Return on Capital Employed (ROCE) | 4.83% |
| Revenue Per Employee | 312,731 |
| Profits Per Employee | 43,141 |
| Employee Count | 1,169 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 3.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.23% in the last 52 weeks. The beta is 1.83, so Vitrolife AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +23.23% |
| 50-Day Moving Average | 17.51 |
| 200-Day Moving Average | 19.69 |
| Relative Strength Index (RSI) | 0.08 |
| Average Volume (20 Days) | 27 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of 359.64 million and earned 49.61 million in profits. Earnings per share was 0.37.
| Revenue | 359.64M |
| Gross Profit | 213.39M |
| Operating Income | 77.11M |
| Pretax Income | 66.85M |
| Net Income | 49.61M |
| EBITDA | 114.77M |
| EBIT | 77.11M |
| Earnings Per Share (EPS) | 0.37 |
Balance Sheet
The company has 105.00 million in cash and 194.37 million in debt, giving a net cash position of -89.36 million.
| Cash & Cash Equivalents | 105.00M |
| Total Debt | 194.37M |
| Net Cash | -89.36M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 9.66 |
| Working Capital | 166.77M |
Cash Flow
In the last 12 months, operating cash flow was 77.51 million and capital expenditures -9.26 million, giving a free cash flow of 68.24 million.
| Operating Cash Flow | 77.51M |
| Capital Expenditures | -9.26M |
| Free Cash Flow | 68.24M |
| FCF Per Share | n/a |
Margins
Gross margin is 59.34%, with operating and profit margins of 21.44% and 13.80%.
| Gross Margin | 59.34% |
| Operating Margin | 21.44% |
| Pretax Margin | 18.59% |
| Profit Margin | 13.80% |
| EBITDA Margin | 31.91% |
| EBIT Margin | 21.44% |
| FCF Margin | 18.98% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.42%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 0.42% |
| Dividend Growth (YoY) | 25.81% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 27.11% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 0.32% |
| Earnings Yield | 2.30% |
| FCF Yield | 3.16% |
Stock Splits
The last stock split was on June 1, 2018. It was a forward split with a ratio of 1.25.
| Last Split Date | Jun 1, 2018 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
Vitrolife AB has an Altman Z-Score of 5.17.
| Altman Z-Score | 5.17 |
| Piotroski F-Score | n/a |